1. Home
  2. GNFT vs ARAI Comparison

GNFT vs ARAI Comparison

Compare GNFT & ARAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNFT
  • ARAI
  • Stock Information
  • Founded
  • GNFT 1999
  • ARAI 2020
  • Country
  • GNFT France
  • ARAI United States
  • Employees
  • GNFT N/A
  • ARAI N/A
  • Industry
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • ARAI Diversified Commercial Services
  • Sector
  • GNFT Health Care
  • ARAI Finance
  • Exchange
  • GNFT Nasdaq
  • ARAI Nasdaq
  • Market Cap
  • GNFT 186.3M
  • ARAI 213.7M
  • IPO Year
  • GNFT 2019
  • ARAI N/A
  • Fundamental
  • Price
  • GNFT $4.11
  • ARAI $6.26
  • Analyst Decision
  • GNFT Strong Buy
  • ARAI
  • Analyst Count
  • GNFT 1
  • ARAI 0
  • Target Price
  • GNFT $13.00
  • ARAI N/A
  • AVG Volume (30 Days)
  • GNFT 3.9K
  • ARAI 245.9K
  • Earning Date
  • GNFT 09-18-2025
  • ARAI 08-14-2025
  • Dividend Yield
  • GNFT N/A
  • ARAI N/A
  • EPS Growth
  • GNFT N/A
  • ARAI N/A
  • EPS
  • GNFT 0.03
  • ARAI N/A
  • Revenue
  • GNFT $73,187,701.00
  • ARAI N/A
  • Revenue This Year
  • GNFT $5.15
  • ARAI N/A
  • Revenue Next Year
  • GNFT N/A
  • ARAI N/A
  • P/E Ratio
  • GNFT $132.29
  • ARAI N/A
  • Revenue Growth
  • GNFT 105.01
  • ARAI N/A
  • 52 Week Low
  • GNFT $2.55
  • ARAI $4.61
  • 52 Week High
  • GNFT $6.42
  • ARAI $40.00
  • Technical
  • Relative Strength Index (RSI)
  • GNFT 58.92
  • ARAI N/A
  • Support Level
  • GNFT $3.71
  • ARAI N/A
  • Resistance Level
  • GNFT $4.12
  • ARAI N/A
  • Average True Range (ATR)
  • GNFT 0.15
  • ARAI 0.00
  • MACD
  • GNFT 0.02
  • ARAI 0.00
  • Stochastic Oscillator
  • GNFT 82.95
  • ARAI 0.00

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

About ARAI Arrive AI Inc. Common Stock

Arrive AI Inc is a technology company. Its patented Autonomous Last Mile (ALM) platform enables secure, efficient delivery to and from a smart, AI-powered mailbox-whether by drone, ground robot, or human courier. The platform provides real-time tracking, smart logistics alerts, and advanced chain-of-custody controls to support shippers, delivery services, and autonomous networks. By combining artificial intelligence with autonomous technology, Arrive AI makes the exchange of goods between people, robots, and drones frictionless and convenient. Its system integrates with smart home devices such as doorbells, lighting, and security systems to streamline the entire last-mile delivery experience.

Share on Social Networks: